CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Rifampin Capsule
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2021-12-22. Latest FDA row update: 2026-10-05.
FDA lists 9 package records, with companies: EPIC PHARMA, LLC, Epic Pharma, LLC, Lupin Pharmaceuticals, Inc.. Package NDCs: 42806-799-01, 42806-799-05, 42806-799-30, 42806-799-60, 42806-801-01, 42806-801-30, 68180-658-06, 68180-659-06, 68180-659-07.
FDA shortage reason: Discontinuation of the manufacture of the drug
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Epic Pharma, LLC | 42806-801-01 | Rifampin, Capsule, 150 mg (NDC 42806-801-01) | Unavailable | 2026-10-05 |
| Epic Pharma, LLC | 42806-801-30 | Rifampin, Capsule, 150 mg (NDC 42806-801-30) | Available | 2026-10-05 |
| Epic Pharma, LLC | 42806-799-01 | Rifampin, Capsule, 300 mg (NDC 42806-799-01) | Unavailable | 2026-10-05 |
| Epic Pharma, LLC | 42806-799-05 | Rifampin, Capsule, 300 mg (NDC 42806-799-05) | Unavailable | 2026-10-05 |
| Epic Pharma, LLC | 42806-799-30 | Rifampin, Capsule, 300 mg (NDC 42806-799-30) | Unavailable | 2026-10-05 |
| Epic Pharma, LLC | 42806-799-60 | Rifampin, Capsule, 300 mg (NDC 42806-799-60) | Available | 2026-10-05 |
| Lupin Pharmaceuticals, Inc. | 68180-658-06 | Rifampin, Capsule, 150 mg (NDC 68180-658-06) | Available | 2026-09-01 |
| Lupin Pharmaceuticals, Inc. | 68180-659-06 | Rifampin, Capsule, 300 mg (NDC 68180-659-06) | Available | 2026-09-01 |
| Lupin Pharmaceuticals, Inc. | 68180-659-07 | Rifampin, Capsule, 300 mg (NDC 68180-659-07) | Available | 2026-09-01 |
Source facts
Grouped generic ingredient: Rifampin Capsule · 9 package records
Therapeutic categories: Anti-Infective
Dosage forms: Capsule
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.